Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization Study
Open Access
- 5 May 2022
- journal article
- research article
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 32 (5), 205-214
- https://doi.org/10.2188/jea.je20200305
Abstract
Background Causal evidence of circulating lipids especially the remnant cholesterol with cardiovascular and cerebrovascular disease (CVD) is lacking. This research aimed to explore the causal roles of extensive lipid traits especially the remnant lipids in CVD. Methods Two-sample Mendelian randomization (TSMR) analysis was performed based on large-scale meta-analysis datasets in European ancestry. The causal effect of 15 circulating lipid profiles including 6 conventional lipids and 9 remnant lipids on coronary heart disease (CHD) and ischemic stroke (IS), as well as the subtypes, was assessed. Results Apo B, TC, LDL-C, and TG were still important risk factors for CHD and MI but not for IS. Apo B is the strongest which increased the CHD and MI risk by 44% and 41%, respectively. The OR(95%CI) of total TG on CHD and MI were 1.25(1.13 to 1.38) and 1.24(1.11 to 1.38), respectively. 1-SD increased M.VLDL.TG, S.VLDL.TG, XS.VLDL.TG, IDL.TG, XL.HDL.TG, and S.HDL.TG particles also robustly increased the risk of CHD and MI by 9%-28% and 9%-27%, respectively. TG in very/extremely large VLDL (XXL.VLDL.TG and XL.VLDL.TG) were insignificant or even negatively associated with CHD (in multivariable MR), and negatively associated with IS as well. Conclusions The remnant lipids presented heterogeneity and two-sided effects for the risk of CHD and IS that may partially rely on the particle size. The findings suggested that the remnant lipids were required to be intervened according to specific components. This research confirms the importance of remnant lipids and provides causal evidence for potential targets for intervention.Keywords
This publication has 40 references indexed in Scilit:
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in AdultsJournal of the American College of Cardiology, 2014
- Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart diseaseJournal of Endocrinological Investigation, 2014
- Lipoprotein Subclass Profiling Reveals Pleiotropy in the Genetic Variants of Lipid Risk Factors for Coronary Heart DiseaseJournal of the American College of Cardiology, 2013
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarctionEuropean Heart Journal, 2012
- Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseNature Genetics, 2011
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statinsThe Lancet, 2005
- Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988